chr2-165090156-T-G

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2

The NM_006922.4(SCN3A):​c.5997A>C​(p.Gln1999His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000317 in 1,578,264 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Q1999P) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00018 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000015 ( 0 hom. )

Consequence

SCN3A
NM_006922.4 missense

Scores

6
13

Clinical Significance

Likely benign criteria provided, single submitter B:1

Conservation

PhyloP100: 1.73

Publications

0 publications found
Variant links:
Genes affected
SCN3A (HGNC:10590): (sodium voltage-gated channel alpha subunit 3) Voltage-gated sodium channels are transmembrane glycoprotein complexes composed of a large alpha subunit with 24 transmembrane domains and one or more regulatory beta subunits. They are responsible for the generation and propagation of action potentials in neurons and muscle. This gene encodes one member of the sodium channel alpha subunit gene family, and is found in a cluster of five alpha subunit genes on chromosome 2. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
SCN3A Gene-Disease associations (from GenCC):
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: Illumina, ClinGen
  • developmental and epileptic encephalopathy, 62
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • epilepsy, familial focal, with variable foci 4
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • undetermined early-onset epileptic encephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.027292073).
BP6
Variant 2-165090156-T-G is Benign according to our data. Variant chr2-165090156-T-G is described in ClinVar as [Likely_benign]. Clinvar id is 800264.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.000184 (28/152336) while in subpopulation AFR AF = 0.000673 (28/41592). AF 95% confidence interval is 0.000478. There are 0 homozygotes in GnomAd4. There are 16 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 28 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SCN3ANM_006922.4 linkc.5997A>C p.Gln1999His missense_variant Exon 28 of 28 ENST00000283254.12 NP_008853.3 Q9NY46-3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SCN3AENST00000283254.12 linkc.5997A>C p.Gln1999His missense_variant Exon 28 of 28 1 NM_006922.4 ENSP00000283254.7 Q9NY46-3

Frequencies

GnomAD3 genomes
AF:
0.000184
AC:
28
AN:
152218
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000675
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000835
AC:
17
AN:
203524
AF XY:
0.0000738
show subpopulations
Gnomad AFR exome
AF:
0.000964
Gnomad AMR exome
AF:
0.000105
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000154
AC:
22
AN:
1425928
Hom.:
0
Cov.:
29
AF XY:
0.0000113
AC XY:
8
AN XY:
706308
show subpopulations
African (AFR)
AF:
0.000483
AC:
16
AN:
33136
American (AMR)
AF:
0.0000512
AC:
2
AN:
39050
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25794
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39058
South Asian (SAS)
AF:
0.00
AC:
0
AN:
83048
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51644
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5344
European-Non Finnish (NFE)
AF:
9.18e-7
AC:
1
AN:
1089886
Other (OTH)
AF:
0.0000509
AC:
3
AN:
58968
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000184
AC:
28
AN:
152336
Hom.:
0
Cov.:
32
AF XY:
0.000215
AC XY:
16
AN XY:
74484
show subpopulations
African (AFR)
AF:
0.000673
AC:
28
AN:
41592
American (AMR)
AF:
0.00
AC:
0
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68032
Other (OTH)
AF:
0.00
AC:
0
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000132
Hom.:
0
Bravo
AF:
0.000174
ESP6500AA
AF:
0.000454
AC:
2
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.0000583
AC:
7

ClinVar

Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Jan 25, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.18
T
BayesDel_noAF
Benign
-0.10
CADD
Benign
20
DANN
Benign
0.97
DEOGEN2
Benign
0.30
T;.;.;.
Eigen
Benign
-0.15
Eigen_PC
Benign
0.041
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Benign
0.83
T;T;T;T
M_CAP
Uncertain
0.093
D
MetaRNN
Benign
0.027
T;T;T;T
MetaSVM
Uncertain
0.35
D
MutationAssessor
Benign
0.0
N;N;.;.
PhyloP100
1.7
PrimateAI
Benign
0.38
T
PROVEAN
Benign
-1.1
N;N;.;N
REVEL
Uncertain
0.37
Sift
Uncertain
0.0010
D;D;.;D
Sift4G
Uncertain
0.0090
D;D;.;D
Polyphen
0.35, 0.12
.;B;.;B
Vest4
0.21
MutPred
0.20
Loss of solvent accessibility (P = 0.0364);Loss of solvent accessibility (P = 0.0364);.;.;
MVP
0.62
MPC
1.3
ClinPred
0.13
T
GERP RS
4.9
Varity_R
0.19
gMVP
0.36
Mutation Taster
=24/76
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs145220602; hg19: chr2-165946666; API